Page 1 of Clinical Trials for Tibotec Pharmaceutical Limited [SPONSOR-COLLABORATORS], 20 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Last Updated: February 10, 2011
Condition(s): HIV Infections
2
Completed
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
Last Updated: May 15, 2012
Condition(s): HIV-1 Infection
3
Completed
VX-950-TiDP24-C216: A Safety and Efficacy Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
Last Updated: July 18, 2011
Condition(s): Hepatitis C, Chronic
4
Completed
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 HCV
Last Updated: June 22, 2011
Condition(s): Hepatitis C
5
Completed
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Last Updated: June 22, 2011
Condition(s): Hepatitis C
6
Completed
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Last Updated: March 22, 2012
Condition(s): Hepatitis C; HIV Infections
7
Completed
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
Last Updated: April 6, 2010
Condition(s): Hepatitis C
8
Active, not recruiting
Virology Follow up Study in Subjects Previously Treated With Telaprevir
Last Updated: September 28, 2011
Condition(s): Hepatitis C
9
Recruiting
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Last Updated: July 16, 2010
Condition(s): HIV Infections; Hepatitis B Virus
10
Recruiting
Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Last Updated: March 29, 2010
Condition(s): HIV Infections
11
Completed
Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
Last Updated: June 6, 2011
Condition(s): Metastatic Breast Cancer
12
Active, not recruiting
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Last Updated: March 25, 2010
Condition(s): HIV Infections
13
Recruiting
Strategic Timing of Antiretroviral Treatment
Last Updated: May 23, 2012
Condition(s): HIV Infection
14
Completed
Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Last Updated: April 8, 2011
Condition(s): HIV Infections
15
Active, not recruiting
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
Last Updated: June 6, 2011
Condition(s): Acute HIV Infection; Acquired Immunodeficiency Syndrome; Medication Adherence
16
Recruiting
Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling
Last Updated: February 23, 2012
Condition(s): Hepatitis C
17
Completed
Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)
Last Updated: August 31, 2009
Condition(s): HIV Infections
18
Completed
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
Last Updated: May 11, 2011
Condition(s): HIV/AIDS; HIV Infections
19
Completed
Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
Last Updated: August 31, 2009
Condition(s): HIV Infections
20
Terminated
Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients
Last Updated: November 15, 2007
Condition(s): Non-Hodgkin's Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Tibotec+Pharmaceutical+Limited

Page 1 of Clinical Trials for Tibotec Pharmaceutical Limited [SPONSOR-COLLABORATORS], 20 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About